Added to YB: 2024-09-02
Pitch date: 2024-08-30
HIMS [neutral]
Hims & Hers Health, Inc.
+153.99%
current return
Author Info
MBR's Substack is an undergraduate at Seoul Nat'l University sharing investment writeups. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$14.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
growth
Hims & Hers Health, Inc. - $HIMS
HIMS (wait for dip): Strong Q2 with 43.4% YoY subscriber growth to 1.86M, 50%+ revenue growth. Marketing costs down, margins stable. Raised guidance. FCF ~$50M. Personalized solutions up 164% YoY. GLP-1 launch adds $10M revenue. Valuation attractive post-GLP-1 concerns. Buy in stages at $12-13 or 10-15% below current price.
Read full article (3 min)